Popular topics to explore
LUPIN
has launched Risperidone for extended-release injectable suspension, 25 mg per vial, 37.5 mg per vial, and 50 mg per vial, Single-Dose Vials, with 180-day CGT exclusivity in the U.S. This follows the recent approval received from the United States Food and Drug Administration (U.S. FDA). This is Lupin’s first product using proprietary technology from PrecisionSphere, the long-acting injectable (LAI) platform developed by Lupin’s subsidiary Nanomi B.V.’s (Nanomi).
ADANIENT
’ wholly owned subsidiary -- Adani Airport Holdings (AAHL) has executed a Share Purchase Agreement (SPA) on November 12, 2025 with AGHPort Aviation Services (AGHPort) and Indo Thai Airport Management Services (Equity Seller) to acquire 100% stake in AGHPort. Post completion of transaction contemplated in SPA, AGHPort will be 100% owned by AAHL.
BDL
(BDL) has signed a contract worth Rs 2,095.70 crore with Ministry of Defence for supply of Invar Anti-tank missiles for the Indian Army.
Ceigall India has emerged as H1 bidder in Financial Bid Opening dated November 13, 2025 for the tender invited by Government of Punjab water Resources Department, office of the Executive Engineer, (ROPAR). The project involves estimate for clearing choked bed of creek in satluj basin for siswan river outfall in satluj river from sedimentation/agradation from RD. 1680 to 2670 and 3000 to 4410 meter from floods in upcoming monsoon season 2025 and disposing of surplus material.
Muthoot Finance has received approval for an additional equity infusion of Rs 500 crore in Muthoot Money, a wholly-owned subsidiary of the Company. Additional equity infusion is proposed to be made in order to strengthen the capital base and improve the capital adequacy ratio. The Board of Directors of the company at their meeting held on November 13, 2025 has approved the same.#WatchOutFor#StockInNews#FundamentalViews#TechnicalViews#EquityResearch
753 likes·46 comments

















